Investment decisions in the venture capital industry inevitably take place behind closed doors, and despite limited research their mechanics remain a mystery. But now, with unprecedented access to real time deal information, Jeffrey S. Petty and Marc Gruber are able to provide new insights into the venture capital decision making process.
When chemists do drug development they tend not to rely on hunches. Fortunately for the unwell, they prefer the more scientific approach of clinical trials. Yet, when managers tackle business related dilemmas they seem happy to trust to gut feelings and intuition.
OpLab, Laboratory in the Operations Department at HEC Lausanne, has developed a tool to calculate the real value of producing close to demand. And if it were cheaper to “reshore”?
Watch this video by Suzanne de Treville, Professor of Operations Management and OpLab’s Director.
Video: 10 min
The CDF tool is freely available as a public service: cdf-oplab.unil.ch